Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review of unmet needs of older adults in home settings and their implications for novel technological solutions.

Innovation in aging·2025
Same author

A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression.

Frontiers in psychiatry·2021
See all related articles

Related Experiment Video

Updated: Dec 10, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K

Data driven CRO benchmarking for biomarker analysis.

Andrew Dolman1, Xiaojing Yu1, Arkady I Gusev1

  • 1Biomarker Development, Novartis Institutes for BioMedical Research, 220 Massachusetts Ave, Cambridge, MA 02139, USA.

Bioanalysis
|September 5, 2020
PubMed
Summary
This summary is machine-generated.

Benchmarking contract research organizations (CROs) through bioanalytical challenges helps pharmaceutical sponsors assess technical skills and operational capabilities. This approach aids informed vendor selection for bioanalytical and biomarker support.

Keywords:
CRObenchmarkingbioanalysisbiomarkeroutsourcing

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.3K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Related Experiment Videos

Last Updated: Dec 10, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.3K
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Area of Science:

  • Pharmaceutical industry
  • Clinical research
  • Biomarker discovery

Background:

  • Outsourcing is prevalent in pharmaceutical and clinical research sectors.
  • Contract research organizations (CROs) provide essential bioanalytical and biomarker support services.
  • Selecting the right CRO partner is critical for successful research outcomes.

Purpose of the Study:

  • To offer critical insights into contract research organization (CRO) benchmarking and selection.
  • To evaluate CROs using a bioanalytical challenge approach with a fit-for-purpose ligand-binding assay.
  • To assess CROs' technical, scientific, quality, and operational competencies.

Main Methods:

  • Performing a fit-for-purpose ligand-binding assay as a bioanalytical challenge.
  • Conducting method validation and sample analysis to evaluate CRO performance.
  • Assessing real-life performance metrics including communication, time management, and cost.

Main Results:

  • The bioanalytical challenge effectively stress-tested CROs' technical and scientific capabilities.
  • CROs demonstrated their quality systems and operational efficiency during the challenge.
  • Objective assay data and real-life experiences provided a basis for benchmarking.

Conclusions:

  • Benchmarking CROs via bioanalytical challenges provides objective data for vendor selection.
  • This method helps pharmaceutical sponsors make informed decisions regarding outsourcing partners.
  • Successful sponsor-CRO partnerships depend on technical competence, quality, operations, communication, and cost management.